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BACKGROUND AND SIGNIFICANCE
Thoracic injuries occur in approximately one third of trauma patients1. Injuries to pulmonary parenchyma
via blunt or penetrating trauma frequently result in hemo-pneumothorax requiring tube thoracostomy. The
standard of care for initial treatment of a posttraumatic chest injury resulting in posttraumatic effusion, with
or without a pneumothorax, is the placement of a large caliber chest tube2.

Trauma patients have unique risk factors for the development of pleural space infections, one of which is
placement of one or more chest tubes. Tube thoracostomy carries the inherent risk of potential inoculation
of the pleural space3. Penetrating injury also increases the likelihood of a pulmonary infection, as the
penetrating object may transfer infectious material into the thoracic cavity and lead to tissue destruction.
Many trauma patients require prolonged courses of mechanical ventilation, which is an independent risk
factor for pneumonia, known to contribute to pulmonary effusion that can progress to empyema.
Moreover, multi-trauma patients with concomitant abdominal solid or hollow viscus injury or
diaphragmatic violation are at greater risk for the development of persistent pleural effusion and empyema4.

The placement of a chest tube often does not completely drain a post-traumatic effusion that is typically a
collection of blood in the pleural space. Retained hemothorax may be central to the pathogenesis of
posttraumatic empyema3. The combination of undrained blood in the chest cavity with exposure to
pathogenic bacteria from external or internal contamination provides the optimal milieu for the formation
of the thick fibrinous exudate that characterizes an organized empyema, sometimes called “fibrothorax”, or
“trapped lung”5.

There are generally accepted to be three stages in the evolution of empyema2. Stage 1, also called the
exudative phase, responds to thoracentesis or chest tube drainage alone. In stage 2, the fibrinopurulent
stage, the previously sterile pleural effusion becomes infected, leading to the accumulation of inflammatory
cells, fibrin, and debris. The fluid becomes more viscous and fibrin deposition may lead to multiple
loculations. The net effect is to make drainage more difficult; however, empyema in the fibrinopurulent
stage may still be amenable to chest tube drainage.

The transition from stage 1 to 2 may occur quickly, often within twenty-four to forty-eight hours. A thick,
inelastic pleural peel, or rind, that traps and compresses the lung, characterizes stage 3 empyema
(organizing empyema). Knowing the stage of the empyema can be critical to the choice of treatment
modality, as a stage 3 empyema frequently will not respond to any other modality outside of surgical
debridement of the pleural peel4.

There is considerable debate in the literature about the optimal treatment of posttraumatic pleural effusions
that do not resolve after placement of a large bore pleural drain. Available treatment options include
placement of additional large bore thoracostomy tubes, the use of smaller bore image-directed pleural
catheters, infusion of intrapleural fibrinolytics, thoracoscopic drainage by video assisted thoracoscopic
surgery (VATS), or traditional open thoracotomy with decortication5. Most often, a combination of
additional small or large bore drainage tubes with or without fibrinolytics is used initially in an effort to
avoid performing the latter two surgical procedures6.

Success rates with less invasive modalities have proven to be highly variable. A recent study found that the
use of Streptokinase for drainage of empyema does not improve outcomes or length of hospital stay7.
Another study found that the use of percutaneous pleural pigtail catheters in children, while efficacious for
draining serous pleural effusions, were less effective for draining hemothorax, and were not effective for
draining empyema8.

The variability of success with non-surgical modalities may be related to the stage of the empyema at
diagnosis5, making accurate diagnosis and staging of empyema critical to determining the most effective
treatment modality. However, the ability to accurately diagnose the stage of empyema with imaging
techniques is unreliable at best, and subject to variable interpretation5. This may become more problematic
when there is a concomitant pneumonia complicating the clinical and diagnostic picture.

Criteria for the diagnosis of empyema (in any stage) vary from institution to institution2-11,14-16. It has been
suggested that the presence of a pleural peel on CT scan is indicative of a stage 3 empyema, and uniformly
predicts the failure of non-operative treatment5. However, in that same series, chest CT missed the
presence of a pleural peel in 17 of the 31 patients who were documented to have a significant pleural peel
at the time of thoracotomy. The ability to radiographically distinguish an exudative stage 2 empyema from
any other type of fluid collection is limited, which in turn may delay definitive and appropriate treatment.

The University of New Mexico Hospital (UNMH), a Level I trauma center, cares for approximately 150200 trauma patients annually that have significant chest injuries requiring tube thoracostomy. At UNMH,
surgeons on the Trauma Service place and manage all posttraumatic thoracostomy tubes, utilizing large
bore tubes (34 or 36 Fr for adults) under sterile conditions. Currently at UNMH, there is no definitive
algorithm for the management of persistent posttraumatic pleural effusions that fail initial tube
thoracostomy.

This paper describes the preliminary results of an ongoing study evaluating variables for all patients
receiving tube thoracostomy after traumatic chest injury. The purpose of the study is to analyze the risk
factors for failure of primary tube thoracostomy, to determine the outcomes for various treatment
modalities subsequently employed, and to correlate the diagnostic modalities used.

MATERIALS AND METHODS
This was a retrospective study of patients who required tube thoracostomy in the management of traumatic
chest injury and was approved by the Human Research and Review Committee at the University of New
Mexico. The trauma registry database at the University of New Mexico Hospital, a Level I trauma center,
was queried for all patients that were admitted between January 2003 and December 2003 and required the
placement of a chest tube after a traumatic chest injury.

Each patient’s medical paper chart was cross-referenced with his or her computer records to gather the
following data: patient demographics, Injury Severity Score (ISS), type of chest trauma, presence of

abdominal or diaphragmatic injuries, any operations performed on admission, the indication and duration of
each thoracostomy tube, the presence of retained fluid after tube placement was noted, and the need for and
the duration of mechanical ventilation. If pneumonia was diagnosed, the results of cultures, and choice of
antibiotics was recorded. When further treatments (additional thoracostomy tubes, percutaneous catheters,
fibrinolytics, VATS, thoracotomy) were required, the sequence of events, timing, and efficacy was noted.
Total number of chest tubes placed and whether the tube was placed in an outside facility, in the field, in
the Emergency Department, or at the patient’s bedside was also recorded. For patients who ultimately
required either traditional or video assisted thoracotomy with decortication, other modalities that were
employed prior to surgery were noted, as well as whether the patient failed video assisted thoracotomy
prior to undergoing an open thoracotomy with decortication. Total hospital days and ICU length of service
were also documented.

DEFINITIONS:

Significant traumatic chest injury was defined as an injury (hemothorax, pneumothorax, or hemopneumothorax) requiring invasive intervention (chest tube, thoracotomy, VATS).

Posttraumatic effusion is defined as the presence of pleural effusion as read by a radiologist on the
admission chest X-ray or CT scan after admission for trauma.

Retained fluid was defined as the presence or persistence of a pleural effusion after placement of a chest
tube.

The diagnosis of empyema required one of the following: (1) Purulent pleural fluid, documented by the
presence of WBCs on gram stain at thoracentesis, chest tube or pleural catheter insertion, or at
thoracotomy, (2) the presence of an inflammatory pleural peel at thoracotomy or VATS; or (3) radiographic
finding of loculated pleural fluid collections or septated pleural fluid collections, or the presence of
thickened or contrast enhancing pleura on chest CT scan or CXR.

Pneumonia was diagnosed if gram stain and respiratory culture of the patient’s sputum or BAL were
positive for a predominant organism, and if the following clinical criteria were present: a new infiltrate on
CXR; signs of a systemic infection, (i.e., leukocytosis or body temperature of 38.5 degrees C or higher);
increased tracheobronchial secretions, and a deterioration of pulmonary status as manifested by increasing
oxygen requirement.

Chest tube drainage success was defined as either complete drainage of pleural effusion or incomplete
drainage of pleural effusion but concomitant improvement in clinical signs of infection without the need for
employing a secondary modality. Chest tube drainage failure was defined as requirement of a secondary
modality. A secondary modality was defined as the placement of additional large or smaller caliber chest
tubes or percutaneous catheters specifically for a persistent effusion, VATS, or open thoracotomy.

Because this is a report of preliminary data for an observational study, all data will be reported in terms of
percentages and discreet values to delineate trends that were observed.

RESULTS
During the year 2003, there were 156 patients who required tube thoracostomy after a traumatic chest
injury, 43 patients (27.6%) had penetrating injuries and 113 (72.4%) had a blunt mechanism of injury. All
patients had at least one chest tube placed. The average age of the patients was 37.2 years. There were 38
females (24.0%) and 118 males (76.0%). Injury Severity Scores (ISS) averaged 21 with a range of 9 to 54.
There were a total of 263 chest tubes placed during this time period, including those small caliber tubes that
were placed by interventional radiology (IR) under computed tomography guidance. The average number
of chest tubes per patient was 1.7 tubes. The average length of stay (LOS) after admission was 13.6 days.
One hundred and seven patients (68.6%) had successful primary tube thoracostomy and 49 patients
(31.4%) required a secondary intervention and were termed failures of primary tube thoracostomy. Death
occurred in 12 patients and was not directly related to complications of chest tube placement in any of the
twelve.

Table 1. Demographic Data of Patients with Chest Tubes (n= 156)
Characteristics
Age, years
ISS
LOS
Tube Thoracostomy (including IR)
Average Number, per patient
Average Duration, days
Mechanism of Injury
Penetrating
Blunt
Success of Primary Tube Thoracostomy
Failure of Primary Tube Thoracostomy
Deaths
ISS = Injury Severity Scale, LOS = Length of Stay

Mean
37.2
21
13.7
263
1.7
5.7
Mean
43
113
107
49
12

Range
(7-99)
(9-54)
(1-74)
(1-8)
(1-18)
Percent
27.6%
72.4%
68.6%
31.4%
7.7%

Table 2. Characteristics of Patients with Successful and Failed Tube Thoracostomy with Empyema.
Patient Characteristics

Success
(n=107)
36.3
74.8
58 (54.2)
49 (45.8)
55.1
16
1.2
47.7
4.6
12
22.4
19
0.97
25.2

Failure
(n=49)
37.5
65.3
14 (28.6)
35 (71.4)
77.8
14
2.8
79.6
8.6
17
42.8
24
10.2
32.7

Average Age
% blunt chest trauma
# PTX (%)
# HTX or HPTX (%)
% with retained fluid
% pts w/abx prior to CT
Avg. # CT/patient
% Intubated
Avg. # of vent days
Avg. # hospital days
% with Pneumonia
Average ISS
% Bacteremia
% with Abdominal or
Diaphragm Injury
# Deaths
0
12
PTX=pneumothorax, HTX=hemothorax, HPTX=hemopneumothorax

Empyema
(n=17)
38.3
70.6
3 (17.6)
14 (82.4)
85.7
23.5
3.4
64.7
14.7
27
64.7
24
17.6
29.4
1

There were 107 patients in the success group. They had an average age of 36.3 years and there were 80
males and 27 females. Eighty of these patients had blunt chest trauma (74.8%) and 27 had penetrating
trauma (25.2%). The indication for chest tube in 58 patients was pneumothorax (54.2%) and in 49 patients,

the indication was either HTX or HPTX (45.8%). Twenty-seven of the 49 patients with HTX or HPTX had
retained fluid on the first chest x-ray after the placement of the chest tube (55.1%). The average number of
chest tubes per patient was 1.2 for the patients in the success group. Fifty-one patients (47.7%) in this
group were intubated with the average number of vent days totaling 4.6 days. Pneumonia was diagnosed in
24 patients (22.4%). Twenty-seven patients were found to have abdominal injuries (25.2%), and 1 patient
had bacteremia documented by blood culture (0.97%). The average Injury Severity Score (ISS) was 19.

There were 49 patients in the failure group. The average age was 37.5 years and there were 37 males and
12 females. Thirty-two patients (65.3%) sustained blunt chest trauma, while the remaining 17 patients
sustained penetrating injuries (34.9%). The indication for chest tube in 14 patients was PTX (28.6%), and
in the remaining 36, the indication was HTX or HPTX (71.4%). Twenty-eight of the 36 patients with
HTX/HPTX had retained fluid after placement of the chest tube for that indication (77.8%). Seven
received antibiotics prior to chest tube insertion (14%). There was an average of 2.8 chest tubes placed per
patient in this group. Thirty-nine (79.6%) of the patients were intubated and remained mechanically
ventilated for and average of 8.6 days. Pneumonia was diagnosed in 21 patients (42.8%). Sixteen patients
(32.7%) were found to have concomitant abdominal or diaphragmatic injuries. Five patients had
bacteremia (10.2%). The average ISS was 24.

The patients in the empyema group are a subset of the failure group. There were a total of 17 patients that
went on to have empyema (all stages). The average age was 38.3 years, with 5 females and 12 males in the
group. Twelve patients had blunt trauma (70.6%) and 5 had penetrating trauma (29.4%). PTX was the
indication for thoracostomy in 3 patients (17.6%) and the remaining 14 had a chest tube placed for HTX or
HPTX (82.4%). Twelve of the patients who had chest tubes placed for HTX or HPTX (85.7%) had
retained hemothorax after placement of the chest tube on the same side as the empyema. Four patients
(23.5%) received antibiotics prior to the placement of that chest tube. The average number of chest tubes
in this group was 3.4 per patient. Eleven patients were intubated (64.7%) with the average number of
ventilator days totaling 14.7 per patient. A diagnosis of pneumonia was made in 11 patients (64.7%) and

bacteremia occurred in 3 (17.6%). Abdominal injuries were found in 5 patients (29.4%). The average ISS
was 24.

Of the 49 patients who did not have successful primary tube thoracostomy, 12 died (8 within 48 hours of
their injuries, 1 from complications of malignancy, 2 after the family decided to withdraw support, and 1
from overwhelming sepsis). Of those 36 patients who survived and who required secondary interventions,
16 patients had resolution of the effusion after receiving only additional large bore chest tubes as their
secondary intervention. One patient required fibrinolytics to be instilled into a large bore catheter as the
only secondary intervention prior to resolution. The remaining 19 surviving patients that failed primary
and secondary large bore tube thoracostomy required additional interventions as shown in Table 2.

Table 3. Secondary Interventions for Patients Failing Primary Tube Thoracostomy

Patients requiring secondary interventions (does not
include those who died)
Patients requiring secondary large bore CT only
Patients requiring CT+lytics
Patients receiving IR drainage
CT+IR (without lytics or other modality)
CT+IR+lytics+VATS or Thoracotomy
CT+IR+VATS or Thoracotomy
Patients undergoing surgical treatment after primary
and/or secondary tube thoracostomy failure
CT+VATS only
CT+VATS and Thoracotomy
CT+Thoracotomy only

Total
36/156

Percent
23.1%

16/36
1/36
9/36
5/36
2/36
2/36

44.4%
2.7%

10/36
5/36
1/36
4/36

13.8%
5.6%
5.6%

13.8%
2.7%
11.1%

A total of 9 patients received IR drainage in addition to at least one large bore thoracostomy tube. This was
successful in 5 patients and failed in 4 patients. Of the 4 patients that failed IR drainage, 2 received
fibrinolytics and then ultimately required thoracotomy, 1 went directly to thoracotomy after IR drainage
failed, and 1 underwent VATS after initial failure of IR drainage.

Six patients underwent VATS immediately after primary chest tube failure. One of the 6 patients was
found to have a retained hemothorax, 1 had persistent air leak, and 4 were treated for empyema. One of the
4 patients that underwent VATS for empyema had to be converted to open thoracotomy. There were 4
patients that had open thoracotomy performed as the only secondary intervention. Three of the 4 patients

had massive hemothorax, which was not amenable to resolution with chest tubes, and underwent the
thoracotomy upon admission, and 1 had a retained hemothorax.

Table. Characteristics of patients with empyema (n=17)
1
2 3 4 5 6 7 8 9 10
Dx Modality
Tissue cx
x
x x
x
OR peel
x
CT peel
x
Pleural pus
x x x
x
Loculations x
x x
x
x
x
Radiol. dx
x
x

11

12

x

x

13

14

15

x
x

x

16

17

total

x

x

9/17
2/17
3/17
6/17
9/17
3/17

x
x

x
x

x

x

x

Table 4 summarizes the modalities used in the diagnosis of empyema and if a radiologist diagnosed
empyema based on the radiographic findings. Three of the 17 patients were diagnosed by a radiologist.
One of those 3 was diagnosed after placement of an IR drain revealed a positive fluid culture, and the other
2 were diagnosed by the presence of a pleural peel on CT scan. Because not every patient was treated
surgically, we cannot know which patients had a pleural peel upon presentation to the operating room.
However, of the 3 patients who had a pleural peel on CT scan, none were noted to have a pleural peel upon
surgical intervention. Loculations were present on either CT scan or chest x-ray in 8 of the 17 patients,
purulent pleural fluid in 6 of the 17, and a tissue diagnosis was made in 9 of 17 patients.

DISCUSSION
Despite protocol at UNMH, which requires placement of chest tubes under sterile conditions by general
surgery residents with supervision, we found that successful outcome of primary tube thoracostomy occurs
in only 68.6% of patients who require a chest tube as a result of chest trauma. The remaining 31.4% who
fail primary tube thoracostomy receive additional treatment modalities and, in general, require longer
hospital stays.

Several studies have retrospectively determined individual risk factors for failure of tube thoracostomy3-7, 16.
We wanted to confirm that the patient population that failed primary tube thoracostomy at our institution
would demonstrate similar observable trends that would indicate the validity of those risk factors. We did

observe that patients in the failure group collectively demonstrated trends were previously noted in the
literature to be individual risk factors for chest tube failure.

Those patients that failed primary tube thoracostomy tended to have more penetrating chest trauma, were
more likely to have required a chest tube for hemothorax (with or without pneumothorax), and tended to
retain that hemothorax more often than the group that had successful tube thoracostomy. They received
antibiotics prior to placement of the first chest tube less often than the failure group, although they were
more likely to have had pneumonia and/or bacteremia. Also, they tended to have more concomitant
abdominal or diaphragm injuries, were more likely to require intubation, and tended to have longer duration
of mechanical ventilation and hospitalization.

Although it is difficult to infer causality of chest tube failure from any of these risk factors, we may be able
to infer that patients who exhibit these characteristics should be more carefully monitored for diminishing
chest tube output, and should have more aggressive treatments instituted sooner.

As noted above, the patients in the failure group who went on to develop empyema tended to reflect the
trends seen for the failure group in general. However, there were some notable exceptions. While the
authors acknowledge that the percentage of the patient population studied who went on to develop
empyema was small (10.9%), there were observable trends in that group when compared to the group that
failed primary tube thoracostomy that warrant further discussion because they do not correlate with the
literature.

First, a larger percentage of patients with empyema got antibiotics than did either the success or the failure
group. This is compelling because it has been suggested that patients receiving chest tubes routinely
receive prophylactic antibiotics3 to prevent pleural space infections and sepsis. Our observation may attest
to the inefficacy of antibiotics for treatment of empyema once it has progressed past the fibrinopurulent
stage. To determine whether our observation signified this conclusion, it would be necessary to include a
tissue diagnosis for every patient with empyema to determine whether they had progressed past the

fibrinopurulent stage. Because tissue diagnosis is not done routinely at our institution, it would be
necessary to design a prospective study with routine tissue sampling for every patient with suspected
empyema. Additional, our study was designed to assess the same information for every chest tube placed,
including smaller bore IR drains and drains placed after the primary chest tube had failed. Our observation
regarding administration of antibiotics before placement of thoracostomy tubes may also reflect the fact
that the patients with empyema were more likely to have a diagnosed pneumonia or other suspected
infection for which they were already receiving prophylactic antibiotics at the time of the additional chest
tube placements.

Second, the empyema group was less likely to have concomitant abdominal or diaphragmatic injuries than
the failure group. Despite a body of literature that cites inflammatory processes within the abdominal
cavity as being a risk factor for nontrauma patients in the development of empyema4, 10, it appears that this
does not hold true for trauma patients. Our observation may reflect the nature of the abdominal and
diaphragmatic injuries that trauma patients sustain, and that these injuries are almost always repaired
immediately, and do not form the foci of abscess that may develop in a nontrauma patient as a result of a
remote cholecystectomy or splenectomy, both of which are cited as common sources of intraabdominal
abscess.

Third, because the ISS was observed to be exactly the same for the empyema group as the failure group, the
authors are lead to believe that there is a contributing risk factor among trauma patients who develop
empyema that is independent of the severity of their injuries.

Finally, although the empyema group tended to have longer LOS and more mechanical ventilation days,
there were a smaller percentage that were intubated. This seems counterintuitive. We interpreted this
tendency to mean that simply the requirement for intubation may not be an independent risk factor for
empyema and that perhaps the longer LOS and mechanical ventilation days for this patient population were
secondary to the empyema itself.

The most consistent difficulty that we encountered in the collection of data was the inconsistency of the
method of diagnosis and the lack of correlation with tissue diagnosis and pathologic findings to
radiographic findings. The single most compelling observation that we were able to make was that in the
process of diagnosing empyema, much emphasis was placed on the presence of a pleural peel on CT scan,
when in fact, that radiographic finding was present in less than 18% of patients that were diagnosed with
empyema through other diagnostic modalities. This observation corresponds to conclusions previously
noted by other authors who suspect that the presence of a pleural peel on CT scan, which is part of the
diagnostic criteria that radiology uses to diagnose empyema, is infrequently encountered4, 15.

Another objective of this study was to delineate the success of current management strategies in the
treatment of posttraumatic empyema. Because there were only 3 patients that received fibrinolytics, it
would be difficult to assess for a pattern in the use of this modality, other than to state that it is not
frequently used by the trauma surgeons in the management of persistent pleural effusions. However, of
note, both of the 2 patients who were infused with fibrinolytics through IR catheters went on to need open
thoracotomy. The only patient who was successfully treated with fibrinolytics was infused through a largebore chest tube.

IR drains were used to drain fluid collections, but were successful in only 5 of the 9 patients who were
treated in this fashion. Again, the sample size is small. However, it may be suggested that small-bore
percutaneous catheters are not consistently successful enough to recommend their routine use prior to
VATS or open thoracotomy. VATS for empyema was successful in 4 of the 5 patients for whom it was
employed in the treatment of empyema and was uniformly successful when employed for retained
hemothorax or persistent air leak. Open thoracotomy was performed in 7 patients without attempting to
perform VATS first based on attending physician preference. Four open procedures were done for
empyema and 3 were done for hemothorax. There was only 1 conversion from VATS to open thoracotomy
for empyema. All 7 open thoracotomies were successful in the treatment of empyema.

Although the sample size was extremely small, the authors feel that we are beginning to observe trends that
will be maintained with a larger sample size and that when the final data analysis is complete, we will be
able to make recommendations for optimal treatment of posttraumatic empyema.

CONCLUSIONS
The utility in any observational study that assesses for risk factors in the progression of any disease entity is
to attempt to identify those risk factors that can be modified or prevented. Without the benefit of larger
numbers of patients and a control group, it may be difficult to make specific recommendations about the
diagnosis and treatment of posttraumatic empyema based on the information gathered. However, because
we observed certain trends that correlated well with accepted literature, the authors feel that we can make
some general statements about the successful management of tube thoracostomy.

1. Aggressive and thorough drainage of blood in the chest cavity should be the primary goal for any trauma
patient with pleural effusion on chest x-ray after trauma. The presence of retained hemothorax was the
strongest trend that we observed among patients with primary failure. Unlike medical patients, who may
have a myriad of reasons to have serous fluid in the pleural space (malignancy, CHF, pneumonia,
cirrhosis), there is an excellent chance that patients sustaining blunt or penetrating trauma to the chest will
have a pleural effusion that consists of blood.

2. Early, and accurate, diagnosis and treatment of ventilator-associated pneumonia and bacteremia,
although not proven to prevent seeding of the pleural space, may decrease overall length of hospital stay
and diminish ventilator dependence. Further analysis of patients with empyema, and how these entities
affect the development of empyema is warranted.

3. In the diagnosis of empyema, it may be more important to rely on the patient’s clinical presentation in
conjunction with non-radiographic and radiographic diagnostic modalities than to rely exclusively on the
elusive radiographic finding of a pleural peel, which is often either not present or is not interpreted as that.
It will be very important in the next phase of this ongoing study to delineate which radiographic modalities

were employed, and how well they correlate to tissue diagnosis and intraoperative findings. With such a
small sample size in the empyema group, we can only speak to our observations for the preliminary
findings.

4. Although we often use “less invasive” treatment modalities such as IR drains and fibrinolytics, several
studies have advocated for the early use of VATS in the treatment of empyema in the fibrinopurulent stage,
as well as for retained hemothorax and persistent air leak1,6,11-13,15. It may be that although IR drainage is
successful some of the time, when it is not successful, this translates into more hospital days and cost to the
patient, as well as more lifetime exposure to radiation through repeated CT scans and chest x-rays. It has
been suggested that perhaps once a pleural effusion has become loculated, that it should be treated with
VATS and not be attempted to drain with percutaneous pigtail catheters6, 8,11,12-14. A prospective study
would help to define the role of IR drainage in the setting of empyema.

Without question, the limitations of this study are those of an observational study with preliminary results.
Without the remainder of the data, which is to be collected, we have only the ability to report trends and
observations without the benefit of statistical analysis.
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